Comparative evaluation of oculometric variables in graves' ophthalmopathy

Comparative evaluation of oculometric variables in graves' ophthalmopathy

OBJECTIVES: To estimate oculometric parameters of Graves' ophthalmopathy in comparison to healthy eyes using digital photography and digital image analysis. INTRODUCTION: Graves' ophthalmopathy is the main cause of eye proptosis. Because these protrusions cause clinically perceived distort...

Full description

Bibliographic Details
Main Authors:	Hélio Amante Miot, Leonardo Parr dos Santos Fernandes, Edson Nassib Jorge, Daniel Rosito Pivotto, Célia Regina Nogueira, Gláucia Maria Ferreira da Silva Mazeto
Format:	Article
Language:	English
Published:	Elsevier España 2009-01-01
Series:	Clinics
Subjects:	Biometry Eye abnormalities Graves' disease Graves' Ophthalmopathy Photography
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322009000900009

Similar Items

Graves’ ophthalmopathy – thyroid eye disease
by: Dagna Siedlecka, et al.
Published: (2019-08-01)

Steroid Treatment Focused Management of Graves’ Ophthalmopathy
by: Condeng Y. H., et al.
Published: (2024-09-01)

An Appraisal of the Preventive Effect of Statins on the Development of Graves’ Ophthalmopathy: A Hospital-Based Cohort Study
by: Grace Chia-Yen Hsu, et al.
Published: (2024-04-01)

Rituximab therapy in steroid-resistant severe hypothyroid Grave′s ophthalmopathy
by: Aditi Pandit, et al.
Published: (2013-01-01)

Graves’ Ophthalmopathy Misdiagnosed as Relapsing Conjunctivitis
by: Irini P. Chatziralli, et al.
Published: (2010-09-01)

Psychological aspects of Graves’ ophthalmopathy
by: Waleed K W Al-Badri, et al.
Published: (2024-08-01)

Treatment of ophthalmopathy in the course of Graves’ disease
by: Magdalena Woźniak, et al.
Published: (2019-09-01)

Orbital Radiotherapy for Graves’ Ophthalmopathy: Single Institutional Experience of Efficacy and Safety
by: Madalina La Rocca, et al.
Published: (2025-02-01)

Autophagy in graves’ ophthalmopathy
by: Yu-Qing Chen, et al.
Published: (2023-04-01)

Graves’ ophthalmopathy: low-dose dexamethasone reduces retinoic acid receptor-alpha gene expression in orbital fibroblasts
by: Sarah Santiloni Cury, et al.
Published: (2018-05-01)

On selenium deficiency in Graves’ disease patients with autoimmune ophthalmopathy
by: Yu.V. Buldygina, et al.
Published: (2019-04-01)

Risk Factors Associated with the Activity and Severity of Graves’ Ophthalmopathy among Patients at the University of the Philippines Manila-Philippine General Hospital
by: Annabelle Marie Lat, et al.
Published: (2017-09-01)

Asssociation of vitamin D with autoimmune ophthalmopathy in Graves’ disease
by: Yu.V. Buldygina, et al.
Published: (2020-01-01)

Etanercept in the treatment of Graves’ ophthalmopathy with primary hypothyroidism and rheumatoid arthritis
by: Olivera Boskovic, et al.
Published: (2020-01-01)

Retinal and Choroidal Alterations in Thyroid-Associated Ophthalmopathy: A Systematic Review
by: Alexandra Magdalena Ioana, et al.
Published: (2025-02-01)

The Role of Oxidative Stress and Therapeutic Potential of Antioxidants in Graves’ Ophthalmopathy
by: Tzu-Yu Hou, et al.
Published: (2021-12-01)

Long-term outcomes of inferomedial orbital wall decompression in Graves' ophthalmopathy in an Asian population: A 30-year retrospective study
by: Chu-Ying Chung, et al.
Published: (2024-01-01)

Validation of Indonesian Graves’ Ophthalmopathy Quality of Life Questionnaire and Its Association with Clinical Activity and Severity of Graves’ Ophthalmopathy
by: Cecilia Anggraini, et al.
Published: (2024-10-01)

A Case of Thyrotoxic Periodic Paralysis and Graves’ Ophthalmopathy Patient in Coincidence with Chronic Hepatitis B Infection
by: Herry Krisnata Ginting, et al.
Published: (2022-05-01)

Current insights of applying MRI in Graves’ ophthalmopathy
by: Cheng Song, et al.
Published: (2022-09-01)

The Role of FOXP3 Polymorphisms in Graves’ Disease with or without Ophthalmopathy in a Turkish Population
by: Fulya Yaylacıoğlu Tuncay, et al.
Published: (2024-04-01)

Computed tomography and magnetic resonance imaging approaches to Graves’ ophthalmopathy: a narrative review
by: Rafael Luccas, et al.
Published: (2024-01-01)

Evaluation of the Effect of Proptosis on Choroidal Thickness in Graves’ Ophthalmopathy
by: Gamze Yıldırım, et al.
Published: (2020-08-01)

Efficacy of selenium supplementation for mild-to-moderate Graves’ ophthalmopathy in a selenium-sufficient area (SeGOSS trial): study protocol for a phase III, multicenter, open-label, randomized, controlled intervention trial
by: Chae Won Chung, et al.
Published: (2023-04-01)

Study on the correlation between serum IgG4/IgG levels and the development of Graves’ ophthalmopathy
by: Yuanyuan Deng, et al.
Published: (2025-01-01)

Rituximab in the treatment of Graves’ disease and endocrine ophthalmopathy. Opportunities and limitations
by: T. S. Panevin, et al.
Published: (2023-10-01)

Tear-derived exosomal biomarkers of Graves’ ophthalmopathy
by: Ting-Ting Shi, et al.
Published: (2022-12-01)

Update on pathogenesis and immunology of Graves’ ophthalmopathy
by: Larysa Krajewska-Węglewicz, et al.
Published: (2018-12-01)

Graves' ophtalmopathy: natural history and treatment outcomes
by: D Noth, et al.
Published: (2001-10-01)

Thyroid disease and associated ophthalmopathy
by: Ricardo Concepción, et al.
Published: (2022-04-01)

Association between polymorphic markers in candidate genes and the risk of manifestationof endocrine ophthalmopathy in patients with Graves’ disease
by: N A Petunina, et al.
Published: (2018-10-01)

Early Massive Fibrosis of a Single Extraocular Muscle Causing Severe Unilateral Euthyroid Graves’ Ophthalmopathy in a Patient with Hypercholesterolemia Who Smokes
by: Frazzetto G, et al.
Published: (2023-04-01)

Thyroid eye disease or Graves’ orbitopathy: What name to use, and why it matters
by: Lilly H. Wagner, et al.
Published: (2022-11-01)

Combined glucocorticoids and cyclophosphamide in the treatment of Graves’ ophthalmopathy: a systematic review and meta-analysis
by: Qilang Xiang, et al.
Published: (2024-01-01)

Treatment of thyroid associated ophthalmopathy : Comparison between radiotherapy with concurrent steroids and three floor orbital decompression
by: Asok Kumar Saha, et al.
Published: (2013-06-01)

Increased heart rhythm in response to high-dose intravenous methylprednisolone pulse therapy of moderate-to-severe Graves’ orbitopathy.
by: Klaudia Gutowska, et al.
Published: (2023-02-01)

Orbital US-based characteristics in Graves’ disease-associated autoimmune ophthalmopathy
by: Yu.V. Buldygina, et al.
Published: (2020-08-01)

Current and promising therapies based on the pathogenesis of Graves’ ophthalmopathy
by: Xin Zhang, et al.
Published: (2023-11-01)

Transforming growth factor β1 (TGF-β1) in patients with endocrine ophthalmopathy and Graves’ disease: A predictor of treatment efficiency
by: N. Yu. Sviridenko, et al.
Published: (2022-11-01)

Research progress on the pathogenesis of Graves’ ophthalmopathy: Based on immunity, noncoding RNA and exosomes
by: Jingyi Zheng, et al.
Published: (2022-08-01)